atranorin has been researched along with Colonic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erkoc, P; Fürst, R; Geisslinger, G; Henke, M; Ingelfinger, R; Laux, V; Roser, LA; Schiffmann, S; Schmitt, I; Schneider, AK; Ulshöfer, T | 1 |
1 other study(ies) available for atranorin and Colonic Neoplasms
| Article | Year |
|---|---|
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin B1; Endothelial Cells; HEK293 Cells; Histones; Humans; Hydroxybenzoates; Lichens; Mice; Mitosis; NIH 3T3 Cells; Salicylates | 2022 |